+ Watch OPTR
on My Watchlist
A biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products.
FDA approval for Dificid to treat gram positive( C-diff) bacteria, a potentially deadly superbug which causes,clostridium difficile associated diarreah. (CDAD ). This is an alternative drug to Vancomycin which has been the main antibiotic to treat c-diff. In bed with cubist pharmaceuticals.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions